Ara 290 Peptide: A Comprehensive Research Guide to Erythropoietin-Derived Neuroprotection
Introduction to Ara-290 Peptide
Ara 290 is a synthetic peptide derived from erythropoietin (EPO) that has gained significant attention in neuroscience, regenerative medicine, and metabolic research due to its potent neuroprotective, anti-inflammatory, and tissue-repairing properties. Unlike full-length EPO, Ara 290 lacks erythropoietic activity, making it an ideal candidate for studying neuroprotection and tissue regeneration without stimulating red blood cell production.
At Wholesale China Peptides, researchers can access high-purity Ara 290 peptide for controlled laboratory studies. This 1000+ word guide covers everything scientists need to know about Ara-290, including its chemical composition, mechanisms of action, research benefits, dosage protocols, and safety considerations.
What Is Ara-290 Peptide?
Ara 290 is a 11-amino acid peptide derived from the helix B region of erythropoietin (EPO). It was developed to mimic EPO’s tissue-protective effects while avoiding its erythropoietic activity, which can lead to increased hematocrit and thrombosis risk.
Key Features of Ara-290:
✅ Neuroprotective effects – Protects neurons from ischemic and oxidative damage
✅ Anti-inflammatory properties – Reduces pro-inflammatory cytokines and oxidative stress
✅ Tissue repair and regeneration – Enhances wound healing and angiogenesis
✅ Metabolic benefits – Improves insulin sensitivity and glucose metabolism
✅ Non-erythropoietic – Does not stimulate red blood cell production
Ara-290 Peptide Benefits in Research
Ara 290 is studied for its potential therapeutic applications in multiple fields:
1. Neuroprotection & Neurological Research
- Stroke – Reduces infarct size and improves functional recovery
- Traumatic brain injury (TBI) – Protects against neuronal damage and cognitive decline
- Neuropathic pain – Alleviates chronic pain and sensory dysfunction
- Diabetic neuropathy – Improves nerve function and reduces pain
- Alzheimer’s and Parkinson’s disease – Protects against neurodegeneration and oxidative stress
2. Metabolic & Diabetes Research
- Type 2 diabetes – Improves insulin sensitivity and glucose metabolism
- Diabetic complications – Reduces neuropathy, retinopathy, and nephropathy
- Obesity and metabolic syndrome – Enhances metabolic function and reduces inflammation
3. Cardiovascular Research
- Myocardial infarction (heart attack) – Reduces infarct size and improves cardiac function
- Heart failure – Enhances cardiac repair and regeneration
- Atherosclerosis – Reduces inflammation and plaque formation
4. Tissue Repair & Regenerative Medicine
- Wound healing – Accelerates skin and tissue regeneration
- Burns and surgical wounds – Enhances recovery and reduces scarring
- Muscle and tendon repair – Improves recovery from injuries and surgeries
5. Inflammatory & Autoimmune Research
- Rheumatoid arthritis – Reduces joint inflammation and pain
- Inflammatory bowel disease (IBD) – Modulates gut inflammation and immune responses
- Multiple sclerosis – Protects against demyelination and neuroinflammation
Ara-290 Peptide: Chemical Composition & Structure
Molecular Formula:
C₅₈H₉₀N₁₄O₁₆
Molecular Weight:
1259.46 g/mol
Amino Acid Sequence:
Gln-Glu-Glu-Ala-Val-Ser-Gly-His-His-Ser-Ala
Key Structural Features:
- Helix B region of EPO – Derived from amino acids 58-82 of erythropoietin
- Non-erythropoietic – Lacks the erythropoietic domain of full-length EPO
- Small peptide size (11 amino acids) – Allows for rapid absorption and tissue penetration
- Stable and soluble – Suitable for various administration routes
Chemical Properties:
| Property | Details |
|---|---|
| Solubility | Water-soluble (reconstitute with bacteriostatic water) |
| Storage (Lyophilized) | -20°C (stable for 2+ years) |
| Storage (Reconstituted) | 2-8°C (stable for 7-14 days) |
| Half-Life | ~2-4 hours (IV), ~6-8 hours (SC) |
| Purity | ≥98% (HPLC-verified) |
How Ara-290 Works: Mechanisms of Action
Ara 290 exerts its effects by binding to the innate repair receptor (IRR), a heterodimer of the EPO receptor (EPOR) and the β-common receptor (CD131). This binding triggers multiple protective pathways without stimulating erythropoiesis.
1. Neuroprotection & Neuroregeneration
- Activates PI3K/Akt pathway – Promotes neuronal survival and plasticity
- Reduces oxidative stress – Scavenges reactive oxygen species (ROS)
- Inhibits apoptosis – Prevents programmed cell death in neurons
- Enhances neurogenesis – Promotes new neuron formation in the brain
2. Anti-Inflammatory Effects
- Modulates cytokine production – Reduces pro-inflammatory cytokines (TNF-α, IL-6, IL-1β)
- Shifts macrophage polarization – Promotes M2 (anti-inflammatory) macrophages
- Reduces neuroinflammation – Protects against chronic inflammation in the brain
3. Tissue Repair & Angiogenesis
- Stimulates angiogenesis – Enhances blood vessel formation for better tissue oxygenation
- Promotes collagen synthesis – Accelerates wound healing and tissue regeneration
- Enhances stem cell migration – Supports tissue repair and regeneration
4. Metabolic Regulation
- Improves insulin sensitivity – Enhances glucose uptake in muscle and fat cells
- Reduces hepatic steatosis – Decreases liver fat accumulation
- Modulates lipid metabolism – Promotes fatty acid oxidation and reduces lipogenesis
5. Cardioprotection
- Reduces infarct size – Protects heart tissue from ischemic damage
- Enhances cardiac repair – Promotes angiogenesis and tissue regeneration
- Improves cardiac function – Enhances left ventricular ejection fraction (LVEF)
Ara-290 Peptide Dosage Protocols for Research
Since Ara 290 is not approved for human use, dosage guidelines are based on preclinical and clinical research models. Researchers should adjust protocols based on study objectives.
General Dosage Guidelines
| Study Type | Dosage Range | Administration Route | Frequency | Study Duration |
|---|---|---|---|---|
| Neuroprotection | 0.1-1 mg/kg | Intravenous (IV) or Subcutaneous (SC) | Daily | 7-28 days |
| Neuropathic Pain | 0.1-0.5 mg/kg | SC or Intramuscular (IM) | Daily | 14-28 days |
| Metabolic Research | 0.1-1 mg/kg | SC or IP (intraperitoneal) | Daily | 14-28 days |
| Cardiovascular Research | 0.5-2 mg/kg | IV or SC | Daily | 7-14 days |
| Tissue Repair | 0.1-1 mg/kg | SC or Topical | Daily | 7-28 days |
| Inflammatory Research | 0.1-1 mg/kg | SC or IP | Daily | 14-28 days |
Key Dosage Considerations
✔ Start with low doses (0.1 mg/kg) to assess tolerance and efficacy.
✔ Monitor neurological and metabolic parameters throughout the study.
✔ Adjust dosage based on study objectives (e.g., higher doses for cardiovascular research).
✔ Combine with other peptides (e.g., BPC-157 for enhanced tissue repair).
✔ Cycle Ara-290 to prevent tolerance and maintain efficacy.
Potential Side Effects & Safety Considerations
While Ara 290 is generally well-tolerated in research, potential side effects should be monitored:
Common Side Effects (Observed in Animal Models)
| Side Effect | Cause | Mitigation Strategy |
|---|---|---|
| Mild injection site irritation | Subcutaneous administration | Rotate injection sites |
| Transient fatigue | Metabolic changes | Ensure proper hydration and nutrition |
| Mild nausea | Central nervous system effects | Administer with food |
Long-Term Considerations
⚠ Immune modulation – Monitor for autoimmune-like reactions.
⚠ Metabolic effects – May alter glucose and lipid metabolism.
⚠ Tissue overgrowth – Monitor for excessive angiogenesis or fibrosis.
⚠ Drug interactions – May enhance effects of anti-inflammatory or metabolic drugs.
Where to Buy High-Quality Ara 290 Peptide for Research
For researchers seeking pharmaceutical-grade Ara 290 peptide, Wholesale China Peptides offers:
✅ ≥98% Purity (HPLC-verified)
✅ Lyophilized for long-term stability
✅ Batch-specific COAs (Certificate of Analysis)
✅ Bulk & wholesale pricing for institutions
✅ Secure, discreet shipping worldwide
Note: Ara-290 peptide is for research use only—not for human consumption, medical treatment, or performance enhancement.
Conclusion: Why Ara 290 Peptide is a Breakthrough in Neuroprotection & Regenerative Research
Ara 290 is one of the most promising peptides for neuroprotection, tissue repair, and metabolic research. Its ability to activate the innate repair receptor (IRR) without stimulating erythropoiesis makes it a valuable tool for studying:
✔ Neurological disorders (stroke, TBI, neuropathic pain, Alzheimer’s, Parkinson’s)
✔ Metabolic diseases (type 2 diabetes, obesity, metabolic syndrome)
✔ Cardiovascular conditions (heart attack, heart failure, atherosclerosis)
✔ Tissue repair and regeneration (wound healing, burns, muscle and tendon repair)
✔ Inflammatory and autoimmune diseases (rheumatoid arthritis, IBD, multiple sclerosis)
For high-purity Ara 290 peptide at competitive prices, visit Wholesale China Peptides.
Disclaimer: This article is for educational and research purposes only. Ara 290 peptide is not approved for human use and should only be used in IRB-approved laboratory settings.
Ready to Buy Ara 290 Peptide for Research?
🔹 Visit Wholesale China Peptides
🔹 Request a COA before purchasing
🔹 Consult with a research advisor for proper dosing protocols

ara 290 peptide
ara 290
ara 290 peptides
ara 290 peptide benefits
ara-290 peptide benefits
ara 290 peptide reddit
ara 290 peptide dosage
ara-290 peptide dosage




Reviews
There are no reviews yet.